Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pablo Arnoletti

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 9, 2004
Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cellsJ Pablo Arnoletti, Donald J Buchsbaum, Zhi-qiang Huang, et al.
Epigenetics Insights|March 1, 2019
<i>K-RAS</i> Mutant Gene Found in Pancreatic Juice Activated Chromatin From Peri-ampullary AdenocarcinomasJoseph Reza, Alvin Jo Almodovar, Milan Srivastava, et al.
The American Surgeon|July 24, 2008
Radiofrequency ablation for unresectable tumors of the liverJ Harrison Howard, Ching-Wei D Tzeng, J Kevin Smith, et al.
Cancer Biology & Therapy|January 8, 2009
Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancerJ Harrison Howard, Andrey Frolov, Ching-Wei D Tzeng, et al.
Cancer|June 6, 2006
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcomaChing-Wei D Tzeng, John B Fiveash, Richard A Popple, et al.
The Journal of Surgical Research|October 24, 2007
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patientsChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Surgery|March 27, 2007
Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancerChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
American Journal of Surgery|April 23, 2010
Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinomaAndrey Frolov, J Spencer Liles, Andrew V Kossenkov, et al.
Annals of Surgical Oncology|April 25, 2007
Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib responseChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Plos One|November 7, 2013
Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaPatrick L Garcia, Leona N Council, John D Christein, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 9, 2004
Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cellsJ Pablo Arnoletti, Donald J Buchsbaum, Zhi-qiang Huang, et al.
Epigenetics Insights|March 1, 2019
<i>K-RAS</i> Mutant Gene Found in Pancreatic Juice Activated Chromatin From Peri-ampullary AdenocarcinomasJoseph Reza, Alvin Jo Almodovar, Milan Srivastava, et al.
The American Surgeon|July 24, 2008
Radiofrequency ablation for unresectable tumors of the liverJ Harrison Howard, Ching-Wei D Tzeng, J Kevin Smith, et al.
Cancer Biology & Therapy|January 8, 2009
Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancerJ Harrison Howard, Andrey Frolov, Ching-Wei D Tzeng, et al.
Cancer|June 6, 2006
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcomaChing-Wei D Tzeng, John B Fiveash, Richard A Popple, et al.
The Journal of Surgical Research|October 24, 2007
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patientsChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Surgery|March 27, 2007
Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancerChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
American Journal of Surgery|April 23, 2010
Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinomaAndrey Frolov, J Spencer Liles, Andrew V Kossenkov, et al.
Annals of Surgical Oncology|April 25, 2007
Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib responseChing-Wei D Tzeng, Andrey Frolov, Natalya Frolova, et al.
Plos One|November 7, 2013
Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaPatrick L Garcia, Leona N Council, John D Christein, et al.
Pageof 4